openPR Logo
Press release

Lawsuit filed for Investors who lost money with shares of Treace Medical Concepts, Inc. (NASDAQ: TMCI)

A lawsuit was filed on behalf of investors in Treace Medical Concepts, Inc. (NASDAQ: TMCI) shares.

A lawsuit was filed on behalf of investors in Treace Medical Concepts, Inc. (NASDAQ: TMCI) shares.

An investor, who purchased shares of Treace Medical Concepts, Inc. (NASDAQ: TMCI), filed a lawsuit over alleged violations of Federal Securities Laws by Treace Medical Concepts, Inc. in connection with certain allegedly false and misleading statements.

Investors who purchased shares of Treace Medical Concepts, Inc. (NASDAQ: TMCI) have certain options and for certain investors are short and strict deadlines running. Deadline: June 10, 2025. NASDAQ: TMCI investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

Ponte Vedra, FL based Treace Medical Concepts, Inc., an orthopedic medical device company, engages in the design, manufacture, and marketing of medical devices for foot and ankle surgeons in the United States.

On May 7, 2024, Treace Medical Concepts, Inc issued a release reporting, among other things, that it lowered its full-year 2024 revenue guidance from between $220 million and $225 million to between $201 million and $211 million. During the associated earnings call the same day, Treace Medical Concepts, Inc revealed competition from minimally invasive osteotomy and Lapiplasty "knockoffs" created headwinds for Lapiplasty growth.

Shares of Treace Medical Concepts, Inc. (NASDAQ: TMCI) declined from $15.98 per share on February 12, 2024, to as low as $3.92 per share on May 08, 2024.

On February 27, 2025, Treace Medical Concepts, Inc reported its financial results for the fourth quarter and full year ended December 31, 2024. Treace Medical Concepts, Inc. reported that its Total Revenue rose from $187.11 million in 2023 to $209.35 million in 2024, and that its Net Loss increased from $49.52 million in 2023 to$55.74 million in 2024.

The plaintiff claims that between May 8, 2023, and May 7, 2024, the Defendants failed to disclose that competition impacted the demand for and utilization of its primary product, the Lapiplasty 3D Bunion Correction System (the "Lapiplasty"), that as a result, Treace Medical's revenue declined and the Company needed to accelerate its plans to offer a product that was an alternative to osteotomy (a surgical procedure that involves cutting and realigning a bone to improve its position or function), and that the Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

Those who purchased shares of Treace Medical Concepts, Inc. (NASDAQ: TMCI) have certain options and should contact the Shareholders Foundation.

Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Lawsuit filed for Investors who lost money with shares of Treace Medical Concepts, Inc. (NASDAQ: TMCI) here

News-ID: 3976855 • Views:

More Releases from Shareholders Foundation, Inc.

Lawsuit filed for Investors who lost money with shares of Tronox Holdings plc (NYSE: TROX)
Lawsuit filed for Investors who lost money with shares of Tronox Holdings plc (N …
An investor, who purchased shares of Tronox Holdings plc (NYSE: TROX), filed a lawsuit over alleged violations of Federal Securities Laws by Tronox Holdings plc in connection with certain allegedly false and misleading statements. Investors who purchased shares of Tronox Holdings plc (NYSE: TROX) have certain options and for certain investors are short and strict deadlines running. Deadline: November 3, 2025. NYSE: TROX investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com
Investigation announced for Investors in Petco Health and Wellness Company, Inc. (NASDAQ: WOOF)
Investigation announced for Investors in Petco Health and Wellness Company, Inc. …
An investigation was announced for current long-term investors in shares of Petco Health and Wellness Company, Inc. (NASDAQ: WOOF) concerning potential breaches of fiduciary duties by certain directors of Petco Health and Wellness Company, Inc. Investors who are current long term investors in Petco Health and Wellness Company, Inc. (NASDAQ: WOOF) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation
Investigation announced for Long-Term Investors in RxSight, Inc. (NASDAQ: RXST) over potential Wrongdoing
Investigation announced for Long-Term Investors in RxSight, Inc. (NASDAQ: RXST) …
An investigation was announced for current long-term investors in shares of RxSight, Inc. (NASDAQ: RXST) concerning potential breaches of fiduciary duties by certain directors of RxSight, Inc. Investors who are current long term investors in RxSight, Inc. (NASDAQ: RXST) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm for current long term investors in NASDAQ: RXST
Tesla, Inc. (NASDAQ: TSLA) Investor Alert: Deadline in Lawsuit on October 3, 2025
Tesla, Inc. (NASDAQ: TSLA) Investor Alert: Deadline in Lawsuit on October 3, 202 …
A deadline is coming up on October 3, 2025 in the lawsuit filed for certain investors of Tesla, Inc. (NASDAQ: TSLA) over alleged securities laws violations by Tesla, Inc. Investors who purchased shares of Tesla, Inc. (NASDAQ: TSLA) have certain options and there are strict and short deadlines running. Deadline: October 3, 2025. Tesla, Inc. (NASDAQ: TSLA) stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 -

All 5 Releases


More Releases for Treace

Bunion Market to Experience Growth by 2034, DelveInsight | Companies involved Sy …
Bunion Treatment Market Report provides real-world prescription pattern analysis, emerging drugs, market share of individual therapies, and historical and forecasted 7MM Bunion market size from 2020 to 2034. The report also covers current Bunion treatment practices/algorithms and unmet medical needs to curate the best opportunities and assess the market's underlying potential. Emerging bunion therapies, including Magnezix CS and Lapiplasty 3-Dimensional Bunion Correction, are poised to boost market growth by providing innovative,
Investigation announced for Investors who hold shares of Treace Medical Concepts …
An investigation was announced for long-term investors in shares of Treace Medical Concepts, Inc. (NASDAQ: TMCI) concerning potential breaches of fiduciary duties by certain directors and officers of Treace Medical Concepts, Inc. Investors who are current long term investors in Treace Medical Concepts, Inc. (NASDAQ: TMCI) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm for
Bunion Market to Experience Robust Growth by 2034 - DelveInsight Analysis | High …
Bunion emerging therapies, such as Magnezix CS and Lapiplasty 3-Dimensional Bunion Correction, are expected to significantly drive market growth by offering innovative, minimally invasive alternatives with improved patient outcomes and faster recovery times. These advancements, combined with rising awareness, increasing prevalence-especially among women-and growing demand for effective surgical and non-surgical interventions, are set to propel the bunion market forward in the coming years. DelveInsight has launched a new report on "Bunion
Investigation announced for Investors in Treace Medical Concepts, Inc. (NASDAQ: …
An investigation was announced over potential breaches of fiduciary duties by certain directors at Treace Medical Concepts, Inc. Investors who purchased shares of Treace Medical Concepts, Inc. (NASDAQ: TMCI) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm concerns whether certain Treace Medical Concepts, Inc. directors breached their fiduciary duties and caused damage to the company and its
PEEK Implants Market is Booming Worldwide by 2030 | Treace Medical Concepts, Inc …
A comprehensive study of the PEEK Implants Market is carried out by the analysts in this report, taking into consideration key factors like drivers, challenges, recent trends, opportunities, advancements and competitive landscape. This report offers a clear understanding of the present as well as future scenarios of the PEEK Implants industry. Research techniques like PESTLE and Porter's Five Forces analysis have been deployed by the researchers. They have also provided
Investigation announced for Investors in shares of Treace Medical Concepts, Inc. …
An investigation was announced over potential breaches of fiduciary duties by certain officers and directors at Treace Medical Concepts, Inc. Investors who purchased shares of Treace Medical Concepts, Inc. (NASDAQ: TMCI) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm concerns whether certain Treace Medical Concepts, Inc. (directors breached their fiduciary duties and caused damage to the company